SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

AMZN is trending as investors assess its potential amid AI advancements and evolving competition in the cloud sector, with community discussions focusing on its current valuation relative to growth prospects. Despite some expressing frustration with recent performance, many highlight Amazon's robust AWS and e-commerce businesses as key drivers for future gains. Some investors are also weighing AMZN against alternative opportunities in the blockchain space.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta is trending as a potential solution to increase transaction speeds and enhance regulatory compliance in blockchain, with some community members suggesting it could complement larger crypto projects like NVDA, SUI, and BTC. Its focus on institutional financial infrastructure and integrations with companies like Stripe are also key talking points. However, some users express concern regarding the project.

BlackRock Institutional Trust Company N.A. - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending as traders assess the potential impact of a new Fed chair and anticipate rate cuts, amidst discussions on inflation and economic growth. Community talking points revolve around technical patterns, yield levels, and the impact of various economic factors on bond prices. Some traders are expressing concerns about a bond market collapse, while others suggest it's a buying opportunity.

UNI is the governance token for Uniswap, an Automated Market Marker DEX on the Ethereum blockchain. The UNI token allows token holders to participate in the governance of the protocol. Key decisions such as usage of the treasury or future upgrades can be decided through a governance vote.

UniSwap

UNI is trending amid discussions about its potential fee switch and token burn mechanism, which could significantly reduce circulating supply and attract institutional interest. The community is actively debating the merits of UNI compared to other protocols like KTA, focusing on Uniswap's strong position in DeFi versus Keeta's focus on compliance and institutional adoption. Some analysts are speculating on potential price targets, with a focus on the potential for substantial growth.

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. It operates through the Cannabis and Plant Propagation segments. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Aurora Cannabis Inc

Aurora Cannabis ($ACB) is trending amid speculation that the Trump administration may loosen federal restrictions on marijuana, potentially reclassifying it to Schedule III. Community discussions revolve around the possibility of increased profitability and the impact on the cannabis sector. However, some caution against chasing naked OTM calls due to high volatility and suggest defined-risk spreads or stock positions instead.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is trending as investors react to a surprise CEO exit and Q3 earnings that beat expectations, while considering the implications of a $1B buyback authorization. The community is actively discussing the future direction of the company and debating whether recent gains signal a true turnaround or a short-term bounce. Many are focused on the company's international growth and potential for renewed innovation.

Advisorshares Trust - AdvisorShares MSOS 2x Daily ETF

AdvisorShares MSOS Daily Leveraged ETF

MSOX is trending as traders discuss its potential upside amid speculation around cannabis rescheduling and potential catalysts in the sector. Community members are weighing the risks and rewards of this leveraged ETF, with some expressing confidence in significant gains while others remain wary of potential volatility. Broader market sentiment and the potential for regulatory changes are key factors influencing the conversation.

The Coca-Cola Co. engages in the manufacturing and marketing of non-alcoholic beverages. It operates through the following segments: Europe, Middle East and Africa, Latin America, North America, Asia Pacific, Global Ventures, and Bottling Investments. The company was founded by Asa Griggs Candler on May 8, 1886 and is headquartered in Atlanta, GA.

Coca-Cola Co

Coca-Cola ($KO) is trending as investors digest a CEO transition announcement for 2026 amid discussions of its valuation and growth prospects. Community members are actively debating its technical outlook, dividend reliability, and potential trading strategies, while some express frustration with perceived market manipulation impacting short-term price movements. Recent analyst ratings and discussions around the stock's performance relative to peers like PepsiCo are also contributing to the buzz.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy Corp

Bloom Energy is trending as investors debate its future amid shifting narratives around AI infrastructure and data center power. Community discussions revolve around Bloom's growth potential and the impact of competitors exploring alternative energy sources for data centers. Some traders are actively capitalizing on the stock's volatility, while long-term investors remain focused on Bloom's fundamentals and future growth prospects in the energy sector.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand (ALGO) is trending amidst discussions about a potential supply cap increase and its impact on tokenomics, with some community members expressing concern over the foundation's token management. Despite bearish sentiment and price fluctuations, some traders see the current price as a buying opportunity, emphasizing Algorand's underlying technology and long-term potential. Discussions also involve comparisons to other blockchains and potential partnerships.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ionis Pharmaceuticals (NASDAQ:IONS) Price Target Raised to $97.00

Bank of America lifted their price target on shares of Ionis Pharmaceuticals from $86.00 to $97.00 and gave the company a "buy" rating in a research note on Tuesday...

450,254 Shares in Ionis Pharmaceuticals, Inc. $IONS Acquired by Norges Bank

Norges Bank bought a new stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange...

Kennedy Capital Management LLC Has $5.22 Million Position in Ionis Pharmaceuticals, Inc. $IONS

Kennedy Capital Management LLC lessened its position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 12.2% in the second quarter, according to the company in its most recent 13F filing...

Hsbc Holdings PLC Purchases 33,461 Shares of Ionis Pharmaceuticals, Inc. $IONS

Hsbc Holdings PLC boosted its position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 44.7% during the second quarter, according to the company in its most recent filing with the...

Capital Fund Management S.A. Sells 26,795 Shares of Ionis Pharmaceuticals, Inc. $IONS

Capital Fund Management S.A. lessened its holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 46.2% in the second quarter, according to the company in its most recent Form 13F...

Insider Selling: Ionis Pharmaceuticals (NASDAQ:IONS) Director Sells $2,262,960.00 in Stock

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Get Free Report) Director Joseph Wender sold 28,000 shares of the company's stock in a transaction that occurred on Monday, December 1st. The shares were...

Pharvaris Stock Gains on HAE Drug Meeting Late-Stage Study Goals

PHVS shares jump as deucrictibant delivers rapid symptom relief in RAPIDe-3, boosting momentum toward a planned 2026 regulatory filing.

Madrigal (MDGL) Up 21.9% Since Last Earnings Report: Can It Continue?

Madrigal (MDGL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Ionis Pharmaceuticals (NASDAQ:IONS) Director Sells $2,262,960.00 in Stock

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Get Free Report) Director Joseph Wender sold 28,000 shares of the firm's stock in a transaction on Monday, December 1st. The shares were sold at an average...

Ionis Pharmaceuticals (NASDAQ:IONS) Hits New 52-Week High - Still a Buy?

Ionis Pharmaceuticals (NASDAQ:IONS) Sets New 52-Week High - What's Next...

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$1.32	--	--	N/A
Q3 '25	-$1.22	-$0.80	34.33%	BEAT
Q2 '25	-$0.09	$0.70	868.38%	BEAT
Q1 '25	-$1.10	-$0.93	15.28%	BEAT
Q4 '24	-$1.12	-$0.66	40.85%	BEAT

IONS
Ionis Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest IONS News

IONSIonis Pharmaceuticals Inc